Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
Earnings for Divi's Laboratories Limited (DIVISLAB.NS)
Earnings in 2023 (TTM): $253.29 M
According to Divi's Laboratories Limited's latest financial reports the company's current earnings (TTM) are $253.29 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Divi's Laboratories Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $253.29 M | $187.37 M |
| 2022 | $277.37 M | $213.6 M |
| 2021 | $431.35 M | $346.68 M |
| 2020 | $312.2 M | $232.37 M |
| 2019 | $213.07 M | $161.2 M |
| 2018 | $217.24 M | $158.41 M |
| 2017 | $144.19 M | $102.7 M |
| 2016 | $163.4 M | $124.18 M |
| 2015 | $161.38 M | $130.2 M |
| 2014 | $125.54 M | $99.72 M |
| 2013 | $116.04 M | $90.56 M |
| 2012 | $91.49 M | $70.5 M |
| 2011 | $79.7 M | $62.45 M |
| 2010 | $55.32 M | $50.27 M |
| 2009 | $45.12 M | $39.85 M |
| 2008 | $52.49 M | $48.79 M |
| 2007 | $44.21 M | $40.7 M |
| 2006 | $-25,673,403 | $21.76 M |
| 2005 | $12.38 M | $8.14 M |